1. Home
  2. CTMX vs URG Comparison

CTMX vs URG Comparison

Compare CTMX & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • URG
  • Stock Information
  • Founded
  • CTMX 2008
  • URG 2004
  • Country
  • CTMX United States
  • URG United States
  • Employees
  • CTMX N/A
  • URG N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • URG Precious Metals
  • Sector
  • CTMX Health Care
  • URG Basic Materials
  • Exchange
  • CTMX Nasdaq
  • URG Nasdaq
  • Market Cap
  • CTMX 596.2M
  • URG 587.4M
  • IPO Year
  • CTMX 2015
  • URG N/A
  • Fundamental
  • Price
  • CTMX $3.32
  • URG $1.69
  • Analyst Decision
  • CTMX Strong Buy
  • URG Strong Buy
  • Analyst Count
  • CTMX 5
  • URG 4
  • Target Price
  • CTMX $5.80
  • URG $2.50
  • AVG Volume (30 Days)
  • CTMX 3.0M
  • URG 12.6M
  • Earning Date
  • CTMX 11-07-2025
  • URG 11-06-2025
  • Dividend Yield
  • CTMX N/A
  • URG N/A
  • EPS Growth
  • CTMX 263.20
  • URG N/A
  • EPS
  • CTMX 0.49
  • URG N/A
  • Revenue
  • CTMX $141,100,000.00
  • URG $39,488,000.00
  • Revenue This Year
  • CTMX N/A
  • URG N/A
  • Revenue Next Year
  • CTMX N/A
  • URG $199.04
  • P/E Ratio
  • CTMX $6.79
  • URG N/A
  • Revenue Growth
  • CTMX 18.01
  • URG 149.20
  • 52 Week Low
  • CTMX $0.40
  • URG $0.55
  • 52 Week High
  • CTMX $3.91
  • URG $2.35
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 55.87
  • URG 50.57
  • Support Level
  • CTMX $3.21
  • URG $1.53
  • Resistance Level
  • CTMX $3.91
  • URG $1.63
  • Average True Range (ATR)
  • CTMX 0.26
  • URG 0.16
  • MACD
  • CTMX -0.06
  • URG -0.04
  • Stochastic Oscillator
  • CTMX 30.59
  • URG 26.67

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About URG Ur Energy Inc (Canada)

Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.

Share on Social Networks: